Literature DB >> 9605092

Hemodilution and whole body oxygen balance during normothermic cardiopulmonary bypass in dogs.

B L Liam1, W Plöchl, D J Cook, T A Orszulak, R C Daly.   

Abstract

OBJECTIVE: The purpose of this study was to determine the minimum hematocrit value that can support whole body oxygen consumption during normothermic cardiopulmonary bypass. The effect of hemodilution on peripheral resistance, whole body oxygen delivery, and oxygen consumption was determined over a range of hematocrit values.
METHODS: Measurements were obtained during 38 degrees C cardiopulmonary bypass with progressive normovolemic hemodilution (hematocrit value 40% to 9%) in nine dogs. Dextran 70 (6%) was used as a diluent. Anesthesia consisted of high-dose fentanyl and midazolam. A mean arterial pressure of 60 mm Hg was maintained throughout cardiopulmonary bypass via increases in pump flow.
RESULTS: Progressive hemodilution was associated with a decreasing total peripheral resistance. During normothermic cardiopulmonary bypass with a whole blood prime, the whole body oxygen consumption approximated values previously reported in dogs under nonbypass conditions. Oxygen delivery and whole body oxygen uptake were maintained between a hematocrit value of 39% and 25%. Significant decreases for both were seen when the hematocrit value was reduced to 18% and below.
CONCLUSIONS: A hematocrit level greater than 18% was needed to maintain systemic oxygen delivery and consumption during warm cardiopulmonary bypass. The critical hematocrit value may be higher under bypass than nonbypass conditions because the flow increases that are practical during cardiopulmonary bypass do not approximate those seen in response to hemodilution of the intact circulation. Finally, the critical hematocrit value for the body may be higher than that required for the brain during warm cardiopulmonary bypass.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9605092     DOI: 10.1016/S0022-5223(98)70422-2

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  5 in total

1.  Perioperative serum levels of tumour-necrosis-factor alpha (TNF-alpha), IL-1 beta, IL-6, IL-10 and soluble IL-2 receptor in patients undergoing cardiac surgery with cardiopulmonary bypass without and with correction for haemodilution.

Authors:  A Roth-Isigkeit; T V Borstel; M Seyfarth; P Schmucker
Journal:  Clin Exp Immunol       Date:  1999-11       Impact factor: 4.330

2.  A rodent model of emergency cardiopulmonary bypass resuscitation with different temperatures after asphyxial cardiac arrest.

Authors:  Fei Han; Manuel Boller; Wenhui Guo; Raina M Merchant; Joshua W Lampe; Thomas M Smith; Lance B Becker
Journal:  Resuscitation       Date:  2009-11-18       Impact factor: 5.262

3.  The correlation of post-operative acute kidney injury and perioperative anaemia in patients undergoing cardiac surgery with cardiopulmonary bypass.

Authors:  Tautvydas Baranauskas; Agnė Kaunienė; Milda Švagždienė; Edmundas Širvinskas; Tadas Lenkutis
Journal:  Acta Med Litu       Date:  2019

4.  Examination of physiological function and biochemical disorders in a rat model of prolonged asphyxia-induced cardiac arrest followed by cardio pulmonary bypass resuscitation.

Authors:  Junhwan Kim; Tai Yin; Ming Yin; Wei Zhang; Koichiro Shinozaki; Mary A Selak; Kirk L Pappan; Joshua W Lampe; Lance B Becker
Journal:  PLoS One       Date:  2014-11-10       Impact factor: 3.240

5.  Investigation of the pathophysiology of cardiopulmonary bypass using rodent extracorporeal life support model.

Authors:  Ru-Wen Chang; Chien-Ming Luo; Hsi-Yu Yu; Yih-Sharng Chen; Chih-Hsien Wang
Journal:  BMC Cardiovasc Disord       Date:  2017-05-15       Impact factor: 2.298

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.